Goldman Sachs full research note summary:
Pfizer (PFE) reinstated as Buy with $30 target.
WellPoint (WLP) raised to Buy from Neutral, but Aetna (AET) cut to Neutral from Buy.
Current fiscal estimates hiked on ACE, AHL, HCC, CB, PTP, RNR, XL by 1% to 2%. Current fiscal estimates trimmed slightly on Chicos FAS (CHS) and Dow Chemical (DOW).
Atmos Energy (ATO) started as Neutral.
ALERT: Take This Retirement Quiz Now (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
